CN112274626A - A Chinese medicinal composition for treating cancer - Google Patents

A Chinese medicinal composition for treating cancer Download PDF

Info

Publication number
CN112274626A
CN112274626A CN202011524767.6A CN202011524767A CN112274626A CN 112274626 A CN112274626 A CN 112274626A CN 202011524767 A CN202011524767 A CN 202011524767A CN 112274626 A CN112274626 A CN 112274626A
Authority
CN
China
Prior art keywords
parts
cancer
treating
traditional chinese
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202011524767.6A
Other languages
Chinese (zh)
Inventor
夏孔彪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202011524767.6A priority Critical patent/CN112274626A/en
Publication of CN112274626A publication Critical patent/CN112274626A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284Atractylodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/40Cornaceae (Dogwood family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • A61K36/575Magnolia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/62Nymphaeaceae (Water-lily family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/72Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725Ziziphus, e.g. jujube
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/894Dioscoreaceae (Yam family)
    • A61K36/8945Dioscorea, e.g. yam, Chinese yam or water yam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994Coix (Job's tears)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9064Amomum, e.g. round cardamom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine composition for treating cancer, which is characterized by comprising the following raw materials in parts by weight: 3.5 to 4.5 parts of astragalus, 2.0 to 3.0 parts of angelica, 2.0 to 2.5 parts of yam, 1.5 to 2.0 parts of tuckahoe, 2.0 to 2.5 parts of coix seed, 1.5 to 2.5 parts of gordon euryale seed, 1.0 to 2.0 parts of liquorice, 1.5 to 2.0 parts of rhizoma atractylodis, 1.5 to 2.5 parts of cinnamon, 2.0 to 3.0 parts of prepared rehmannia root, 1.5 to 2.5 parts of dogwood fruit, 1.0 to 1.5 parts of magnolia officinalis, 1.0 to 1.5 parts of amomum fruit, 1.5 to 3.5 parts of ginger and 1.5 to 3.5 parts of Chinese date. The invention is a broad-spectrum anticancer drug, and is suitable for liver cancer, gastric cancer, lung cancer, pancreatic cancer, rectal cancer, lymph cancer, parotid cancer, brain cancer, breast cancer, uterine cancer, ovarian cancer, bone cancer, thyroid cancer and the like. The traditional Chinese medicine composition has the effects of strengthening the resistance of a cancer patient to cancer cells by tonifying qi and consolidating the constitution, promoting blood circulation to remove blood stasis, tonifying liver and kidney, eliminating dampness and strengthening spleen, nourishing heart and soothing nerves, treating both symptoms and root causes, playing a role in improving the immunity synergistically, solving the symptoms caused by cancer, increasing the curative effect of western medicine, preventing and treating postoperative recurrence of cancer, relieving the pain of the patient and prolonging the life of the patient.

Description

A Chinese medicinal composition for treating cancer
Technical Field
The invention relates to the field of medicaments for treating cancers by taking Chinese herbal medicines as raw materials, in particular to a Chinese medicinal composition for treating cancers.
Background
Cancer is a cancer in which normal tissue cells undergo a mutation in a gene to cause abnormal proliferation under certain adverse factors or specific environmental conditions. Or the immunity of the human body is reduced to a certain degree due to various reasons, the cancer cells begin to grow synthetically, the virus is generated at various parts of the human body, the virus lives and proliferates by absorbing nutrition through blood, the virus is stubborn on blood and lymph transfer, and the virus is difficult to cure in the field of world medicine and science at present. Moreover, with the pace of industry increasing, the incidence of disease is increasing. Cancer is characterized by fast growth speed, invasive growth, easy occurrence of hemorrhage, necrosis, ulcer and the like, and often distant metastasis, which causes emaciation, weakness, anemia, inappetence, fever, serious organ function impairment and the like of a human body, and finally death of a patient. At present, the health and life safety of human beings are seriously threatened. Such as liver cancer, stomach cancer, lung cancer, esophageal cancer, etc., even today, the medical technology is highly developed, and thus effective prevention and thorough treatment of cancer are a major problem in the medical field today.
At present, the treatment of cancer generally carries out surgical excision on a cancer lesion part, but the cancer is easy to relapse after the surgery; the mechanism of postoperative recurrence can be divided into two broad categories, one is continuous recurrence from residual primary lesions, and the other is discontinuous metastasis recurrence. The recurrence forms include local recurrence, lymph node recurrence, and organ recurrence. The recurrent part has recurrent anastomotic oral part, recurrent broken end suture part, recurrent stump except anastomotic orifice and broken end, and recurrent peripheral part of stump. This recurrence severely affects the quality and duration of life of the patient. Therefore, the medicine for preventing and treating the postoperative recurrence of the cancer is also vital to improve the survival treatment of the patients and prolong the survival time.
As for the treatment of cancer, chemotherapy, radiotherapy, immunotherapy, and the like are currently available in addition to surgical treatment. The chemotherapy and the radiotherapy have obvious tumor inhibition effect, but the concomitant side effect is also large. Especially, radiation therapy can inhibit cancer cells and cause serious damage to normal cells. The number of leucocytes of patients after chemotherapy and radiotherapy is greatly reduced. Part of the Chinese medicinal preparation can be used in combination with radiotherapy and chemotherapy to relieve adverse side effects of radiotherapy and chemotherapy, promote recovery of patients, and enhance tolerance to radiotherapy and chemotherapy. Therefore, improvement research on traditional Chinese medicine treatment is needed, more reasonable and unique traditional Chinese medicine composition is prepared and applied to cancer treatment, better treatment effect and treatment side effect alleviation are achieved by matching with western medicine treatment, and the body function is adjusted while symptoms are relieved, so that the physical condition of a patient is improved.
Therefore, the traditional Chinese medicine composition for treating cancer is a problem to be solved urgently, and the traditional Chinese medicine composition solves the symptoms caused by cancer, increases the curative effect of western medicine, prevents and treats postoperative recurrence of cancer, relieves pain of patients and prolongs the life of the patients. The inventor finds a traditional Chinese medicine composition for treating cancer through years of clinical research.
Disclosure of Invention
The invention aims to provide a traditional Chinese medicine composition for treating cancer.
The purpose of the invention is realized by the following technical scheme:
the traditional Chinese medicine composition for treating cancer comprises the following raw materials in parts by weight:
3.5 to 4.5 parts of astragalus, 2.0 to 3.0 parts of angelica, 2.0 to 2.5 parts of yam, 1.5 to 2.0 parts of tuckahoe, 2.0 to 2.5 parts of coix seed, 1.5 to 2.5 parts of gordon euryale seed, 1.0 to 2.0 parts of liquorice, 1.5 to 2.0 parts of rhizoma atractylodis, 1.5 to 2.5 parts of cinnamon, 2.0 to 3.0 parts of prepared rehmannia root, 1.5 to 2.5 parts of dogwood fruit, 1.0 to 1.5 parts of magnolia officinalis, 1.0 to 1.5 parts of amomum fruit, 1.5 to 3.5 parts of ginger and 1.5 to 3.5 parts of Chinese date.
The traditional Chinese medicine composition for treating cancer is prepared from the following raw materials in parts by weight:
3.5 parts of astragalus, 2.5 parts of angelica, 2.5 parts of yam, 1.5 parts of tuckahoe, 2.0 parts of coix seed, 1.5 parts of gordon euryale seed, 1.5 parts of liquorice, 1.5 parts of rhizoma atractylodis, 2.5 parts of cinnamon, 2.5 parts of prepared rhizome of rehmannia, 1.5 parts of dogwood fruit, 1.5 parts of magnolia officinalis, 1.5 parts of fructus amomi, 2.5 parts of ginger and 2.5 parts of Chinese date.
The traditional Chinese medicine composition for treating cancer is prepared from the following raw materials in parts by weight:
4.0 parts of astragalus, 2.5 parts of angelica, 2.0 parts of Chinese yam, 1.5 parts of tuckahoe, 2.0 parts of coix seed, 1.5 parts of gordon euryale seed, 1.0 part of liquorice, 2.0 parts of rhizoma atractylodis, 2.0 parts of cinnamon, 2.0 parts of prepared rhizome of rehmannia, 2.5 parts of dogwood fruit, 1.0 part of magnolia officinalis, 1.0 part of fructus amomi, 1.5 parts of ginger and 1.5 parts of Chinese date.
The traditional Chinese medicine composition for treating cancer is prepared from the following raw materials in parts by weight:
4.5 parts of astragalus, 2.0 parts of angelica, 2.5 parts of yam, 2.0 parts of tuckahoe, 2.5 parts of coix seed, 2.0 parts of gordon euryale seed, 1.5 parts of liquorice, 1.5 parts of rhizoma atractylodis, 2.0 parts of cinnamon, 3.0 parts of prepared rhizome of rehmannia, 2.0 parts of dogwood fruit, 1.0 part of magnolia officinalis, 1.5 parts of fructus amomi, 3.5 parts of ginger and 3.0 parts of Chinese date.
The traditional Chinese medicine composition for treating cancer is prepared from the following raw materials in parts by weight:
3.5 parts of astragalus, 2.0 parts of angelica, 2.5 parts of yam, 1.5 parts of tuckahoe, 2.5 parts of coix seed, 2.5 parts of gordon euryale seed, 2.0 parts of liquorice, 1.5 parts of rhizoma atractylodis, 2.5 parts of cinnamon, 2.5 parts of prepared rhizome of rehmannia, 2.5 parts of dogwood fruit, 51 parts of magnolia officinalis, 1.0 part of fructus amomi, 3.0 parts of ginger and 3.5 parts of Chinese date.
The traditional Chinese medicine composition for treating cancer is characterized in that a pharmaceutically acceptable carrier is added to prepare a preparation suitable for medicinal use.
The traditional Chinese medicine composition for treating cancer can be added with a pharmaceutically acceptable carrier when being prepared into a medicament, and the pharmaceutically acceptable carrier can be: starch, magnesium stearate, mannitol, sorbitol, sorbic acid or potassium salt, sodium metabisulfite, sodium bisulfite, sodium thiosulfate, cysteine hydrochloride, thioglycolic acid, methionine, vitamin A, vitamin C, vitamin E, vitamin D, azone, disodium EDTA, calcium sodium EDTA, carbonate, acetate, phosphate or aqueous solution thereof of monovalent alkali metal, hydrochloric acid, acetic acid, sulfuric acid, phosphoric acid, amino acid, sodium chloride, potassium chloride, sodium lactate, xylitol, dextran, glycine, silicon derivatives, cellulose and derivatives thereof, alginate, gelatin, polyvinylpyrrolidone, glycerol, propylene glycol, ethanol, tween 60-80, span 60-80, beeswax, lanolin, liquid paraffin, cetyl alcohol, gallic acid esters, agar, triethanolamine, basic amino acid, calcium carbonate, calcium bicarbonate, surfactant, polyethylene glycol, sodium thiosulfate, calcium gluconate, sodium hydrogen sulfate, Cyclodextrin, beta-cyclodextrin, phospholipid material, kaolin, talcum powder, calcium stearate, etc.
The Chinese medicinal composition for treating cancer can be any medicinal dosage forms, and the dosage forms comprise: tablets, sugar-coated tablets, film-coated tablets, enteric-coated tablets, capsules, hard capsules, soft capsules, oral liquids, buccal tablets, granules, pills, powder, dropping pills and the like. Preferred oral dosage forms are: tablet, capsule, granule, pill, powder, and dripping pill.
A preparation method of powder, granule and solution of Chinese medicinal composition for treating cancer comprises:
respectively drying and crushing the raw materials into fine powder of 120 meshes, mixing the fine powder according to the proportion, carrying out radiation sterilization, inspecting, and packaging, wherein each bag is 5 g or 10 g to prepare powder; or further adding appropriate amount of sucrose and soluble starch, granulating with ethanol, drying, and packaging to obtain granule.
Decocting the raw materials with water, boiling for 20-40 min, filtering to obtain medicinal liquid, adding water, decocting for 2 times with the same water amount for the first time, boiling for 20-30 min, filtering to obtain medicinal liquid, and mixing the medicinal liquids.
The main indications of the meridian entering and the function of the various medicinal materials used in the invention are as follows:
astragalus root: enter spleen and lung meridians. Sweet in flavor and slightly warm in nature. The efficacy is as follows: invigorating qi, invigorating yang, consolidating superficial resistance, inducing diuresis to alleviate edema, expelling toxin, and promoting granulation. The main treatment is as follows: qi deficiency of the spleen and lung, sinking of middle-jiao, poor appetite, loose stool, shortness of breath, hypodynamia, exterior deficiency, spontaneous perspiration, abscess, deep-rooted carbuncle, and chronic ulcer.
Chinese angelica: it enters liver, heart and spleen meridians. Sweet and pungent in flavor and warm in nature. The efficacy is as follows: tonify blood, activate blood, regulate menstruation, alleviate pain, moisten intestines to relieve constipation. Can be used for treating blood deficiency, sallow complexion, giddiness, palpitation, menoxenia, amenorrhea, dysmenorrhea, asthenia cold, abdominal pain, rheumatalgia, traumatic injury, superficial infection, pyocutaneous disease, intestinal dryness, and constipation.
Chinese yam: enter lung, spleen and kidney meridians. Is flat and nontoxic. The efficacy is as follows: to invigorate the spleen, tonify the lung, strengthen the kidney and replenish vital essence. It can be used for treating diarrhea due to spleen deficiency, chronic dysentery, cough due to asthenia, diabetes, spermatorrhea, leukorrhagia, and frequent micturition. Tonify spleen and stomach, promote the production of body fluid and nourish lung, tonify kidney and astringe essence. Can be used for treating spleen deficiency, anorexia, chronic diarrhea, lung deficiency, cough, asthma, spermatorrhea, leukorrhagia, frequent micturition, and diabetes due to deficiency heat. The bran-parched rhizoma Dioscoreae has effects of invigorating spleen and invigorating stomach. Can be used for treating spleen deficiency, anorexia, diarrhea, loose stool, and leukorrhagia.
Tuckahoe, poria cocos: enter heart, spleen and kidney meridians. Sweet and bland in flavor and mild in nature. The functions are as follows: tonify heart and spleen, induce diuresis and induce tranquilization. The main treatment is as follows: diarrhea due to spleen deficiency, dyspepsia, edema, palpitation, insomnia, dysuria, cough and sputum.
Coix seed: enter spleen, lung and stomach meridians. The efficacy is as follows: invigorate spleen, remove dampness, remove arthralgia, expel pus. The main treatment is as follows: dysuria, edema, beriberi, spleen deficiency and diarrhea, rheumatic arthralgia, spasm and urgency of tendons and vessels, pulmonary abscess and intestinal abscess.
Gorgon fruit: it enters spleen and kidney meridians. Sweet and astringent taste, mild in nature. The efficacy is as follows: tonify kidney, secure essence, tonify spleen, check diarrhea, remove dampness and stop leukorrhagia. Can be used for treating spermatorrhea, enuresis, frequent micturition, spleen deficiency, chronic diarrhea, whitish and turbid urine, and leukorrhagia.
Licorice root: it enters heart, lung, spleen and stomach meridians. Sweet in flavor and neutral in nature. The efficacy is as follows: invigorating spleen and replenishing qi, clearing away heat and toxic material, eliminating phlegm and relieving cough, relieving spasm and pain, and harmonizing the drugs. Can be used for treating weakness of spleen and stomach, asthenia, palpitation, short breath, cough, excessive phlegm, abdominal and limb spasm, pain, carbuncle, swelling, sore, and drug toxicity and strong nature.
Rhizoma atractylodis: it enters spleen, stomach and liver meridians. Pungent and bitter with warm nature. The efficacy is as follows: dry dampness and invigorate spleen, dispel wind and cold, improve vision. Can be used for treating damp obstruction of middle warmer, abdominal distention, diarrhea, edema, tinea pedis, atrophic debility cramped, rheumatalgia, wind-cold type common cold, night blindness, dim eyesight, and astringency.
Cinnamon: it enters kidney, spleen, heart and liver meridians. Pungent and sweet in flavor and strongly hot in nature. Has the effects of tonifying fire, supporting yang, guiding fire to the origin, dispelling cold, relieving pain, and warming and dredging channels and collaterals. Can be used for treating sexual impotence, cold womb, cold pain of waist and knee, asthma due to kidney deficiency, floating of deficient yang, giddiness, conjunctival congestion, cold pain of heart and abdomen, vomiting and diarrhea due to deficiency cold, cold hernia, abdominal pain, dysmenorrhea, and amenorrhea.
Prepared rhizome of rehmannia: enter liver and kidney meridians. Sweet and warm. The efficacy is as follows: to nourish yin and enrich blood. It is indicated for deficiency of yin and blood, atrophy and weakness of waist and knees, fatigue, cough, steaming bone, seminal emission, metrorrhagia, menoxenia, diabetes, scanty urine, deafness and blurred vision.
Cornus officinalis: it enters liver and kidney meridians. Sour and astringent taste, slightly warm in nature. The efficacy is as follows: tonify liver and kidney, astringe and induce depletion. Can be used for treating vertigo, tinnitus, soreness of waist and knees, sexual impotence, spermatorrhea, enuresis, frequent micturition, metrorrhagia, leukorrhagia, sweating, asthenia, internal heat, and diabetes.
Magnolia officinalis: it enters spleen, stomach, lung and large intestine meridians. Bitter and pungent in flavor and warm in nature. The efficacy is as follows: dry dampness and resolve phlegm, descend qi and remove fullness. Can be used for treating damp stagnation, abdominal distention, vomiting, diarrhea, food stagnation, qi stagnation, abdominal distention, constipation, phlegm retention, asthma, and cough.
Amomum fruit: spleen, stomach and kidney meridians. Pungent flavor and warm nature. Has effects of eliminating dampness, promoting appetite, warming spleen, relieving diarrhea, regulating qi-flowing, and preventing miscarriage. Can be used for treating damp turbidity obstruction in middle energizer, abdominal distention, inappetence, deficiency-cold of spleen and stomach, emesis, diarrhea, vomiting, and threatened abortion.
Ginger: it enters lung, spleen and stomach meridians. Pungent in flavor and slightly warm in nature. The efficacy is as follows: relieve exterior syndrome, dispel cold, warm middle energizer, arrest vomiting, warm lung, relieve cough, and remove toxicity. Can be used for treating wind-cold type common cold, spleen and stomach cold syndrome, stomach cold emesis, cough due to lung cold, and fish and crab toxin.
Chinese date: it enters spleen and stomach meridians. Sweet taste, warm nature and no toxicity. The efficacy is as follows: tonify spleen and qi, nourish heart and induce tranquilization. Can be used for treating diarrhea due to spleen deficiency, palpitation, insomnia, night sweat, thrombocytopenic purpura, and hysteria of women; preventing blood transfusion reaction, reducing serum glutamic-pyruvic transaminase, resisting tumor, resisting oxidation, lowering blood pressure, reducing cholesterol, protecting liver, improving immunity, preventing and treating cerebral ischemia, resisting allergy, preventing and treating cardiovascular disease, and preventing and treating osteoporosis and anemia.
The traditional Chinese medicine composition for treating cancer has reasonable formula, good compatibility and special medicine essence, can better play a synergistic effect when the medicines are used together, not only reduces adverse reaction of western medicine treatment, but also is a broad-spectrum anticancer medicine, and is suitable for liver cancer, gastric cancer, lung cancer, pancreatic cancer, rectal cancer, lymph cancer, brain cancer, breast cancer, uterine cancer, ovarian cancer, bone cancer, thyroid cancer and the like. The traditional Chinese medicine composition has the effects of strengthening the resistance of a cancer patient to cancer cells by tonifying qi and consolidating the constitution, promoting blood circulation to remove blood stasis, tonifying liver and kidney, eliminating dampness and strengthening spleen, nourishing heart and soothing nerves, treating both symptoms and root causes, playing a role in improving the immunity synergistically, solving the symptoms caused by cancer, increasing the curative effect of western medicine, preventing and treating postoperative recurrence of cancer, relieving the pain of the patient and prolonging the life of the patient.
According to the traditional Chinese medicine, the cancer comprises two aspects of internal cause and external cause, wherein the internal cause is a mental factor, improper diet, viscera and meridians are disordered, and healthy qi is damaged; in addition, pathogenic toxin invades the body and causes blockage of the channels and collaterals and stagnation of qi and blood coagulation. The pathogenesis of tumor is mainly manifested in qi, blood, phlegm, toxicity and deficiency, i.e. invasion of toxic pathogen, stagnation of qi and blood, phlegm-dampness retention, deficiency and impairment of five viscera and other pathological changes. In the course of tumor development, the decline of vital qi and the increasing of pathogenic toxin are the main characteristics. The invention fully realizes the close connection between the whole body and the local part of a cancer patient according to the occurrence and development characteristics of cancer and by applying the holistic concept and dialectical thinking of the traditional Chinese medicine theory, thereby comprehensively considering the coordination and cooperation of the whole body and the local part in treatment, adjusting and balancing yin, yang, qi and blood of a human body and achieving the purposes of strengthening body resistance and eliminating evil and treating both symptoms and root causes.
Detailed Description
The following examples are provided for illustrative purposes only and are not intended to limit the scope of the claims, and other alternatives that may occur to those skilled in the art from consideration of the specification are intended to be within the scope of the claims.
Example 1
The composition is prepared from the following raw materials in parts by weight:
3.5 parts of astragalus, 2.5 parts of angelica, 2.5 parts of yam, 1.5 parts of tuckahoe, 2.0 parts of coix seed, 1.5 parts of gordon euryale seed, 1.5 parts of liquorice, 1.5 parts of rhizoma atractylodis, 2.5 parts of cinnamon, 2.5 parts of prepared rhizome of rehmannia, 1.5 parts of dogwood fruit, 1.5 parts of magnolia officinalis, 1.5 parts of fructus amomi, 2.5 parts of ginger and 2.5 parts of Chinese date.
Example 2
The composition is prepared from the following raw materials in parts by weight:
4.0 parts of astragalus, 2.5 parts of angelica, 2.0 parts of Chinese yam, 1.5 parts of tuckahoe, 2.0 parts of coix seed, 1.5 parts of gordon euryale seed, 1.0 part of liquorice, 2.0 parts of rhizoma atractylodis, 2.0 parts of cinnamon, 2.0 parts of prepared rhizome of rehmannia, 2.5 parts of dogwood fruit, 1.0 part of magnolia officinalis, 1.0 part of fructus amomi, 1.5 parts of ginger and 1.5 parts of Chinese date.
Example 3
The composition is prepared from the following raw materials in parts by weight:
4.5 parts of astragalus, 2.0 parts of angelica, 2.5 parts of yam, 2.0 parts of tuckahoe, 2.5 parts of coix seed, 2.0 parts of gordon euryale seed, 1.5 parts of liquorice, 1.5 parts of rhizoma atractylodis, 2.0 parts of cinnamon, 3.0 parts of prepared rhizome of rehmannia, 2.0 parts of dogwood fruit, 1.0 part of magnolia officinalis, 1.5 parts of fructus amomi, 3.5 parts of ginger and 3.0 parts of Chinese date.
Example 4
The composition is prepared from the following raw materials in parts by weight:
3.5 parts of astragalus, 2.0 parts of angelica, 2.5 parts of yam, 1.5 parts of tuckahoe, 2.5 parts of coix seed, 2.5 parts of gordon euryale seed, 2.0 parts of liquorice, 1.5 parts of rhizoma atractylodis, 2.5 parts of cinnamon, 2.5 parts of prepared rhizome of rehmannia, 2.5 parts of dogwood fruit, 51 parts of magnolia officinalis, 1.0 part of fructus amomi, 3.0 parts of ginger and 3.5 parts of Chinese date.
The preparation method and the usage and dosage of the powder, the granules and the solution of the traditional Chinese medicine composition for treating cancer in the embodiments 1-4 are as follows:
(1) the raw materials are respectively dried and crushed into 120-mesh fine powder, mixed according to the proportion, irradiated for sterilization, inspected and packaged, and each bag is 5 g or 10 g to prepare powder; or further adding appropriate amount of sucrose and soluble starch, granulating with ethanol, drying, and packaging to obtain granule. The usage and dosage are as follows: oral administration, starting with a small dose, increasing the dose gradually or following a physician's prescription. Usually the initial dose is 5-10 g once, 3 times a day.
(2) Decocting the above materials in water, boiling for 20 min, filtering to obtain medicinal liquid, adding water, decocting for 2 times with the same amount of water for the first time, boiling for 20 min, filtering to obtain medicinal liquid, and mixing the medicinal liquids. The usage and dosage are as follows: the oral preparation is taken 30-50 ml each time in the morning and evening or in the morning, at noon and at night.
Generally, 30 days is a course of treatment, and 3 courses of treatment are taken each year.
Clinical trial studies for many years show that the traditional Chinese medicine composition for treating cancer prepared by the embodiment of the invention is used for clinically observing more than one thousand cases of various malignant tumors, wherein the treatment cases comprise liver cancer, gastric cancer, lung cancer, rectal cancer, lymph cancer, brain cancer, breast cancer, uterine cancer, ovarian cancer, bone cancer, liver embryonic carcinoma, thyroid cancer and the like, and the data of the treatment cases are more complete 609 cases, wherein 61 cases comprise liver cancer, 113 cases comprise stomach cancer, 132 cases comprise lung cancer, 76 cases comprise rectal cancer, 8 cases comprise lymph cancer, 65 cases comprise breast cancer, 39 cases comprise uterine cancer, 17 cases comprise ovarian cancer, 35 cases comprise bone cancer and 63 cases comprise other cancers. Generally, cancer cells are inhibited and the body weight begins to increase after about 2 to 3 months of administration, and can be eliminated or inhibited by about half a year for light people and about one year for heavy people, and the body is recovered. The medication is then required to consolidate the treatment outcome for half a year or one year.
The curative effect standard is as follows:
1. and (3) complete alleviation: disappearance of all measurable tumor parameters;
2. partial mitigation: the measurable tumor parameters are reduced by 50 percent or more, and no clinical new lesion appears;
3. and (3) stabilizing: one or more measurable tumor lesions have not decreased in size to 50%, or not increased in size to 25%;
4. deterioration: the measurable tumor lesions increased by more than 25%, or new lesions appeared.
And (4) observing results:
complete remission was 32 cases, accounting for 5.3%; the partial remission was 141 cases, accounting for 23.2%; the stability does not change to 226 cases, accounting for 37.1%; the deterioration rate is 210 cases, accounting for 34.5 percent.
In 536 of the cancer patients, after observation for 2-6 months, the white blood cell index is checked several times, and in 305 of the cancer patients, the white blood cell index is not reduced basically in 56.9%. The composition can relieve the toxic and side effects of radiotherapy and chemotherapy, promote the recovery of patients and enhance the tolerance of radiotherapy and chemotherapy.
Clinical typical cases:
case 1: wangzhi, male, 61 years old, primary stomach cancer 1.9x1.2cm, stomachache and vomiting, the tumor shrinks to 1.4x0.9cm after taking the medicine for one month, 1.2 x0.6cm after two months, 0.8x 0.5cm after three months, and the medicine disappears after six months and is recovered to health.
Case 2: a certain woman in the forest, 55 years old, cervical cancer 2.2 x1.0cm, 1.6 x1.0cm after taking the medicine for one month, 1.0 x0.5cm after three months, and 5kg of body weight increase after six months.
Case 3: the pancreatic cancer of a certain male, age 67, 5.9 x2.6cm, is reduced to 4.4 x2.3cm after being taken for two months, is reduced to 3.7 x1.5cm after three months, is completely disappeared after six months, does not relapse, is recovered to be healthy, and can be used for self-care life.
Case 4: plum, male, 68 years old, rectal cancer of 2.1x1.2cm, stool with blood, stool in thin strip shape, stool recovery after half a month of administration, excision of focus, and regular examination in hospital for more than ten years, all indexes of result are normal.
Case 5: when a certain woman is old and 50 years old, breast cancer is removed by operation, bone cancer is transferred after five years, the medicine is taken for one year, the medicine is taken for 3 months after 3 years, the medicine is taken for more than three years, and the result is checked regularly in hospitals, all indexes are normal, and no relapse occurs.
Case 6: sunzhi, female, age 67, brain cancer 2.1x 2.0cm, recurrent brain cancer after breast cancer surgery a few years ago, metastatic lymphoma. Giving up the radiotherapy to start taking the medicine, checking in a hospital regularly after 6 months, obtaining a result that all indexes are normal, completely eliminating the tumor after one year, increasing the weight by 6kg, and living normally.
Case 7: a certain Wang, a woman in age of 58 years, breast cancer of 1.5x 1.1cm, metastatic lymph cancer, and lymph metastasis of 2 parts of breast cancer at the time of operation, the patient starts to take the medicine because transaminase is too high and chemotherapy is not performed, all indexes gradually return to normal after being regularly checked by a hospital every year in 3 years, and the weight of the patient is increased by 5 kg.
Case 8: certain Zhao, male, 59 years old, throat cancer 1.1x 0.6cm, tumor contracted to 0.8x0.4cm after one month of administration, 0.5 x0.3cm after two months, and all disappeared after three months, all indexes gradually recovered to normal and body weight increased by 8 kg.
Clinical treatment tests for many years prove that cancer cells are inhibited after the medicine is generally taken for 2-3 months, the body gradually improves after 5-6 months, and the cancer cells are reduced or disappeared in different degrees within 1 year after the medicine is taken, so that the health is recovered. The traditional Chinese medicine composition has better effect on early and middle cancer patients and patients with advanced cancer, and the life of most advanced cancer patients can be prolonged if the advanced cancer patients are accidentally discovered.

Claims (6)

1. The traditional Chinese medicine composition for treating cancer is characterized by comprising the following raw materials in parts by weight:
3.5 to 4.5 parts of astragalus, 2.0 to 3.0 parts of angelica, 2.0 to 2.5 parts of yam, 1.5 to 2.0 parts of tuckahoe, 2.0 to 2.5 parts of coix seed, 1.5 to 2.5 parts of gordon euryale seed, 1.0 to 2.0 parts of liquorice, 1.5 to 2.0 parts of rhizoma atractylodis, 1.5 to 2.5 parts of cinnamon, 2.0 to 3.0 parts of prepared rehmannia root, 1.5 to 2.5 parts of dogwood fruit, 1.0 to 1.5 parts of magnolia officinalis, 1.0 to 1.5 parts of amomum fruit, 1.5 to 3.5 parts of ginger and 1.5 to 3.5 parts of Chinese date.
2. The traditional Chinese medicine composition for treating cancer according to claim 1, which is prepared from the following raw materials in parts by weight:
3.5 parts of astragalus, 2.5 parts of angelica, 2.5 parts of yam, 1.5 parts of tuckahoe, 2.0 parts of coix seed, 1.5 parts of gordon euryale seed, 1.5 parts of liquorice, 1.5 parts of rhizoma atractylodis, 2.5 parts of cinnamon, 2.5 parts of prepared rhizome of rehmannia, 1.5 parts of dogwood fruit, 1.5 parts of magnolia officinalis, 1.5 parts of fructus amomi, 2.5 parts of ginger and 2.5 parts of Chinese date.
3. The traditional Chinese medicine composition for treating cancer according to claim 1, which is prepared from the following raw materials in parts by weight:
4.0 parts of astragalus, 2.5 parts of angelica, 2.0 parts of Chinese yam, 1.5 parts of tuckahoe, 2.0 parts of coix seed, 1.5 parts of gordon euryale seed, 1.0 part of liquorice, 2.0 parts of rhizoma atractylodis, 2.0 parts of cinnamon, 2.0 parts of prepared rhizome of rehmannia, 2.5 parts of dogwood fruit, 1.0 part of magnolia officinalis, 1.0 part of fructus amomi, 1.5 parts of ginger and 1.5 parts of Chinese date.
4. The traditional Chinese medicine composition for treating cancer according to claim 1, which is prepared from the following raw materials in parts by weight:
4.5 parts of astragalus, 2.0 parts of angelica, 2.5 parts of yam, 2.0 parts of tuckahoe, 2.5 parts of coix seed, 2.0 parts of gordon euryale seed, 1.5 parts of liquorice, 1.5 parts of rhizoma atractylodis, 2.0 parts of cinnamon, 3.0 parts of prepared rhizome of rehmannia, 2.0 parts of dogwood fruit, 1.0 part of magnolia officinalis, 1.5 parts of fructus amomi, 3.5 parts of ginger and 3.0 parts of Chinese date.
5. The traditional Chinese medicine composition for treating cancer according to claim 1, which is prepared from the following raw materials in parts by weight:
3.5 parts of astragalus, 2.0 parts of angelica, 2.5 parts of yam, 1.5 parts of tuckahoe, 2.5 parts of coix seed, 2.5 parts of gordon euryale seed, 2.0 parts of liquorice, 1.5 parts of rhizoma atractylodis, 2.5 parts of cinnamon, 2.5 parts of prepared rhizome of rehmannia, 2.5 parts of dogwood fruit, 51 parts of magnolia officinalis, 1.0 part of fructus amomi, 3.0 parts of ginger and 3.5 parts of Chinese date.
6. The Chinese medicinal composition for treating cancer according to claim 1, wherein a pharmaceutically acceptable carrier is added to prepare a pharmaceutically acceptable preparation.
CN202011524767.6A 2020-12-22 2020-12-22 A Chinese medicinal composition for treating cancer Withdrawn CN112274626A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011524767.6A CN112274626A (en) 2020-12-22 2020-12-22 A Chinese medicinal composition for treating cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011524767.6A CN112274626A (en) 2020-12-22 2020-12-22 A Chinese medicinal composition for treating cancer

Publications (1)

Publication Number Publication Date
CN112274626A true CN112274626A (en) 2021-01-29

Family

ID=74425984

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011524767.6A Withdrawn CN112274626A (en) 2020-12-22 2020-12-22 A Chinese medicinal composition for treating cancer

Country Status (1)

Country Link
CN (1) CN112274626A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112546151A (en) * 2020-12-28 2021-03-26 崔正易 A medicine containing Lentinus Edodes and Chinese medicinal materials for treating cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108295224A (en) * 2018-05-04 2018-07-20 辽宁金砚生物科技股份有限公司 A kind of Chinese medicine composition for treating cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108295224A (en) * 2018-05-04 2018-07-20 辽宁金砚生物科技股份有限公司 A kind of Chinese medicine composition for treating cancer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
王勇强等: "化疗加扶正中草药治疗恶性肿瘤的临床观察", 《吉林医学》 *
黄智芬等: "八珍汤加味配合化疗治疗晚期大肠癌31例临床观察", 《河北中医》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112546151A (en) * 2020-12-28 2021-03-26 崔正易 A medicine containing Lentinus Edodes and Chinese medicinal materials for treating cancer

Similar Documents

Publication Publication Date Title
CN102309716B (en) Traditional Chinese medicine composition for treating morbid leucorrhea and preparation method thereof
CN101757566A (en) Traditional Chinese medicine composition for treating colon cancer and preparation method thereof
CN101019985B (en) Constipation treating Chinese medicine
CN106390013A (en) Compound traditional Chinese medicine composition capable of inhibiting colorectal liver metastases as well as preparation method and application thereof
CN100496585C (en) Chloasma treating Chinese medicine preparation
CN100593417C (en) Chinese traditional medicine for treating gastric cancer and bone cancer
CN103611091B (en) A kind of Chinese medicine composition for the treatment of cancer of pancreas
CN100431593C (en) Chinese medicinal formulation for treating hydrocephalus
CN112656925A (en) Medicinal and edible plant traditional Chinese medicine composition for preventing cancers
CN112274626A (en) A Chinese medicinal composition for treating cancer
CN101773647B (en) Chinese medicine composition for treating duodenal carcinoma and preparation method thereof
CN110742990B (en) Traditional Chinese medicine composition for treating non-alcoholic simple fatty liver, preparation and application
CN103908616B (en) The medicament of tumor remission patient radiotherapy side effect and preparation method
CN100450537C (en) Chinese medicinal formulation for treating prostate hyperplasia
CN103908520A (en) Spleen-invigorating and kidney-nourishing preparation for relieving postoperative radiotherapy reaction of tumor patients and preparation method thereof
CN104225016A (en) Drug composition for treating spleen and stomach deficiency type chronic atrophic gastritis
CN117771334B (en) Traditional Chinese medicine composition for regulating autophagy and resisting breast tumors and nodules as well as preparation method and application thereof
CN107233505A (en) It is a kind of to be used to treat pill medicine of constipation and preparation method thereof
CN100333777C (en) Medicine for improving enterogastric function after radiation chemiotherapy
CN100394948C (en) Leucoderma treating Chinese medicine prepn
CN105521370A (en) Pharmaceutical preparation for treating colon cancer and application thereof
CN106924679A (en) A kind of medicine for treating gastric ulcer
CN100415276C (en) A Chinese traditional medicinal preparation for treatment of vitiligo
CN105477336A (en) Spleen-strengthening stomach-harmonizing ointment resistant to side effects of chemotherapy
CN103656014B (en) A kind ofly treat Chinese medicine of diabetes patient's gastrointestinal function decline after abdominal operation and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20210129